ACLX
Price
$68.10
Change
+$1.85 (+2.79%)
Updated
Jun 6 closing price
Capitalization
3.65B
72 days until earnings call
THRD
Price
$5.29
Change
-$0.00 (-0.00%)
Updated
Jun 6 closing price
Capitalization
238.73M
61 days until earnings call
Interact to see
Advertisement

ACLX vs THRD

Header iconACLX vs THRD Comparison
Open Charts ACLX vs THRDBanner chart's image
Arcellx
Price$68.10
Change+$1.85 (+2.79%)
Volume$595.32K
Capitalization3.65B
Third Harmonic Bio
Price$5.29
Change-$0.00 (-0.00%)
Volume$199.43K
Capitalization238.73M
ACLX vs THRD Comparison Chart
Loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
THRD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACLX vs. THRD commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACLX is a Buy and THRD is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (ACLX: $68.10 vs. THRD: $5.29)
Brand notoriety: ACLX and THRD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACLX: 70% vs. THRD: 30%
Market capitalization -- ACLX: $3.65B vs. THRD: $238.73M
ACLX [@Biotechnology] is valued at $3.65B. THRD’s [@Biotechnology] market capitalization is $238.73M. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACLX’s FA Score shows that 0 FA rating(s) are green whileTHRD’s FA Score has 1 green FA rating(s).

  • ACLX’s FA Score: 0 green, 5 red.
  • THRD’s FA Score: 1 green, 4 red.
According to our system of comparison, THRD is a better buy in the long-term than ACLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACLX’s TA Score shows that 7 TA indicator(s) are bullish while THRD’s TA Score has 3 bullish TA indicator(s).

  • ACLX’s TA Score: 7 bullish, 2 bearish.
  • THRD’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, ACLX is a better buy in the short-term than THRD.

Price Growth

ACLX (@Biotechnology) experienced а +9.73% price change this week, while THRD (@Biotechnology) price change was +1.54% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.04%. For the same industry, the average monthly price growth was +14.90%, and the average quarterly price growth was +1.90%.

Reported Earning Dates

ACLX is expected to report earnings on Aug 18, 2025.

THRD is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+9.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACLX($3.65B) has a higher market cap than THRD($239M). ACLX YTD gains are higher at: -11.201 vs. THRD (-48.591). THRD has higher annual earnings (EBITDA): -66.25M vs. ACLX (-153.96M). ACLX has more cash in the bank: 543M vs. THRD (272M). THRD has less debt than ACLX: THRD (3M) vs ACLX (53.2M). ACLX has higher revenues than THRD: ACLX (76.8M) vs THRD (0).
ACLXTHRDACLX / THRD
Capitalization3.65B239M1,528%
EBITDA-153.96M-66.25M232%
Gain YTD-11.201-48.59123%
P/E RatioN/AN/A-
Revenue76.8M0-
Total Cash543M272M200%
Total Debt53.2M3M1,772%
TECHNICAL ANALYSIS
Technical Analysis
ACLXTHRD
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 1 day ago
81%
Momentum
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
84%
MACD
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
81%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 2 days ago
84%
Declines
ODDS (%)
Bearish Trend 5 days ago
79%
Bearish Trend 17 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
THRD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AMBFX35.820.08
+0.22%
American Funds American Balanced F2
ELFNX88.65N/A
N/A
Elfun Trusts
NIQAX14.90N/A
N/A
Neuberger Berman International Eq A
HEOSX17.01N/A
N/A
Hartford Climate Opportunities R4
FEQAX13.38N/A
N/A
Fidelity Advisor Hedged Equity Fund A

ACLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACLX has been loosely correlated with CGON. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if ACLX jumps, then CGON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACLX
1D Price
Change %
ACLX100%
+2.79%
CGON - ACLX
57%
Loosely correlated
+1.05%
KRYS - ACLX
57%
Loosely correlated
+3.26%
RNA - ACLX
55%
Loosely correlated
+1.83%
BEAM - ACLX
53%
Loosely correlated
+9.26%
XNCR - ACLX
53%
Loosely correlated
+5.81%
More

THRD and

Correlation & Price change

A.I.dvisor indicates that over the last year, THRD has been loosely correlated with APGE. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if THRD jumps, then APGE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To THRD
1D Price
Change %
THRD100%
N/A
APGE - THRD
42%
Loosely correlated
+8.84%
NVAX - THRD
42%
Loosely correlated
+6.58%
IGMS - THRD
41%
Loosely correlated
+6.45%
ACLX - THRD
35%
Loosely correlated
+2.79%
ADMA - THRD
35%
Loosely correlated
+3.36%
More